Literature DB >> 25439075

The fight against gastric cancer - the IARC Working Group report.

Rolando Herrero1, Jin Young Park2, David Forman2.   

Abstract

Gastric cancer is the third cause of cancer death worldwide, and Helicobacter pylori infection causes almost 90% of non-cardia cancers, the predominant type. H. pylori infection is treatable, and in clinical trials there is evidence of a 30-40% reduction in incidence of gastric cancer among treated subjects. However, with a few exceptions, there are no public health programmes for gastric cancer prevention. In December 2013, the International Agency for Research on Cancer (IARC), organized a Working Group of international experts to discuss and make recommendations for gastric cancer control. The Working Group considered that the enormous burden of disease, which is not expected to decline in the coming decades, requires decisive public health action to include gastric cancer in cancer control programmes. Interventions should be tailored to the local conditions and consider population-based screening and eradication of H. pylori, in the context of evaluation of feasibility, efficacy and adverse consequences.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Eradication; Gastric cancer; Helicobacter pylori; Prevention

Mesh:

Year:  2014        PMID: 25439075     DOI: 10.1016/j.bpg.2014.10.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  50 in total

1.  Evaluation of a Novel Stool Antigen Rapid Test Kit for Detection of Helicobacter pylori Infection.

Authors:  Toshihiko Kakiuchi; Masumi Okuda; Kazutoshi Hashiguchi; Ichiro Imamura; Aiko Nakayama; Muneo Matsuo
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

2.  Lymph node metastasis in patients with gastric cancer: a multi-modality, morphologic and functional imaging study.

Authors:  Jinman Zhong; Weiwei Zhao; Fang Ren; Shun Qi; Xifu Wang; Tianchu Lv; Zhanliang Su; Hong Yin; Jing Ren; Yi Huan
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.

Authors:  Nan Hu; Zhaoming Wang; Xin Song; Lixuan Wei; Byung Sik Kim; Neal D Freedman; Jiwon Baek; Laurie Burdette; Jiang Chang; Charles Chung; Sanford M Dawsey; Ti Ding; Yu-Tang Gao; Carol Giffen; Yaling Han; Myunghee Hong; Jia Huang; Hee Sung Kim; Woon-Puay Koh; Linda M Liao; Yi Min Mao; You-Lin Qiao; Xiao-Ou Shu; Wen Tan; Chaoyu Wang; Chen Wu; Min-Jie Wu; Yong-Bing Xiang; Meredith Yeager; Jeong Hwan Yook; Jian-Min Yuan; Peng Zhang; Xue-Ke Zhao; Wei Zheng; Kyuyoung Song; Li-Dong Wang; Dongxin Lin; Stephen J Chanock; Alisa M Goldstein; Philip R Taylor; Christian C Abnet
Journal:  Gut       Date:  2015-06-30       Impact factor: 23.059

Review 4.  Identifying the pre-malignant stomach: from guidelines to practice.

Authors:  Jonathan R White; Matthew Banks
Journal:  Transl Gastroenterol Hepatol       Date:  2022-01-25

5.  New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.

Authors:  Kevin David Shield; Claire Marant Micallef; Catherine de Martel; Isabelle Heard; Francis Megraud; Martyn Plummer; Jérôme Vignat; Freddie Bray; Isabelle Soerjomataram
Journal:  Eur J Epidemiol       Date:  2017-12-06       Impact factor: 8.082

6.  Expansion of the tetracycline-dependent regulation toolbox for Helicobacter pylori.

Authors:  Aleksandra W Debowski; Miriam Sehnal; Tingting Liao; Keith A Stubbs; Barry J Marshall; Mohammed Benghezal
Journal:  Appl Environ Microbiol       Date:  2015-09-11       Impact factor: 4.792

Review 7.  Emerging blood-based biomarkers for detection of gastric cancer.

Authors:  Zane Kalniņa; Irēna Meistere; Ilze Kikuste; Ivars Tolmanis; Pawel Zayakin; Aija Linē
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

8.  AMPK activator AICAR promotes 5-FU-induced apoptosis in gastric cancer cells.

Authors:  Yan Wu; Yijun Qi; Hu Liu; Xiaoshan Wang; Huaqing Zhu; Zhengguang Wang
Journal:  Mol Cell Biochem       Date:  2015-10-24       Impact factor: 3.396

9.  Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation.

Authors:  Jung Wook Lee; Su Jin Kim; Cheol Woong Choi; Hyeong Jin Kim; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Hyeong Seok Nam; Dae Gon Ryu
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

10.  The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.

Authors:  M Blanca Piazuelo; Luis E Bravo; Robertino M Mera; M Constanza Camargo; Juan C Bravo; Alberto G Delgado; M Kay Washington; Alicia Rosero; Luz S Garcia; Jose L Realpe; Sandra P Cifuentes; Douglas R Morgan; Richard M Peek; Pelayo Correa; Keith T Wilson
Journal:  Gastroenterology       Date:  2020-11-18       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.